Skip to content

Author

V. Philiponis

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Sequential vaccination matures VRC01-class HIV-1 neutralizing antibodies in humans

Inducing a broadly neutralizing antibody (bnAb) response is a key goal of HIV-1 vaccine development. Despite significant progress, it is unknown whether vaccine-primed B cells can be reactivated and matured to secrete bona fide bnAbs. In the IAVI C107/C110 single-arm, open-label human trial, VRC01-class memory B cells...

T. Caniels, Madhu S. Prabhakaran, S. Agrawal et al. · 0 citations
Open access Sep 2026

Safety and immunogenicity of a recombinant vesicular stomatitis virus-based Sudan virus vaccine in adults in the USA: a single-blind, first-in-human, dose-escalation phase 1 clinical trial.

BACKGROUND A vaccine is needed to prevent Sudan virus (SUDV) disease (SVD), a haemorrhagic fever. We report a first-in-human clinical trial evaluating the safety and immunogenicity of a recombinant vesicular stomatitis virus (rVSV) vaccine expressing the SUDV envelope glycoprotein (rVSVΔG-SEBOV-GP). METHODS In this s...

Dagna S. Laufer, Arianna Marini, V. Philiponis et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.